Novavax scientists declared that their vaccine is 90% more strong against various variants of coronavirus based on a clinical trial in the USA. Approximately 30,000 people participated in this trial.
This is a protein-based virus that is produced from purified viruses to induce an immune response against viral attack.
The company said that the vaccine is 91% effective in the body of participants having severe infections. It also 100% effective in moderate cases of covid attack.
The company also said that there are mild type side effects like headache, fatigue, and muscle pain upon taking the vaccine. Only a few volunteers experienced some mild side effects.
The company aims to synthesize 100 million doses of vaccine every month in the third quarter of 2021 and 150 million doses of vaccine in the 4th quarter of 2021.